Growth factors regulating lymphatic vessels

Current Topics in Microbiology and Immunology

Volumn 251, Issue , 2000, Pages 75-82

  Lymboussaki, A ^a   Achen, M G ^a   Stacker, S A ^a   Alitalo, K ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; CELL SPECIFICITY; CONFERENCE PAPER; LYMPH VESSEL; MICROCIRCULATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

EID: 0033812268     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-57276-0_10     Document Type: Conference Paper

References (44)

1. Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface
2. The fine structure and functioning of tissue channels and lymphatics
3. Role of lymphagenesis in neovascularisation
4. Lymphangiogenesis: Mechanisms, significance and clinical implications
5. Observations on living mammalian lymphatic capillaries, their relation to the blood vessels
6. Angiogenesis and lymphangiogenesis: Analagous mechanisms and homologous growth factors
7. The regeneration of the lymphatics
8. The vascular endothelial growth factor family; proteins which guide the development of the vasculature
9. A structural superfamily of growth factors containing a cystine knot motif
10. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane
11. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
12. Proteolytic processing regulates receptor specificity and activity of VEGF-C
13. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium in skin and vascular tumors
14. Vascular endothelial growth factor receptor-3
15. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
16. A recombinant mutant vascular endothelial growth factor-C that has lost VEGFR-2 binding, activation, and vascular permeability activities
17. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
18. The lymphatic system in human embryos, with a consideration of the morphology of the system as a whole
19. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
20. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4
21. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemial
22. VEGF-C induces angiogenesis in vivo
23. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors
24. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk-1) and VEGF receptor 3 (Fit-4)
25. Biosynthesis of VEGF-D involves proteolytic processing which generates non-covalent dimers
26. Embryonic expression pattern of the murine figf gene, a growth factor belonging to platelet-derived growth factor/vascular endothelial growth factor family
27. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development
28. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family
29. c-fos is required for malignant progression of skin tumors
30. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro
31. A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability
32. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines
33. Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts
34. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor
35. Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase
36. Lymphatic endothelium and Kaposi's sarcoma cells detected by antibodies against VEGFR-3
37. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer
38. Interaction with the phosphotyrosine binding domain/phosphotyrosine interacting domain of SHC is required for the transforming activity of the FLT4/VEGFR3 receptor tyrosine kinase
39. Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptor
40. Signal transduction in human hematopoietic cells by vascular endothelial growth factor related protein, a novel ligand for the FLT4 receptor
41. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3
42. Mechanisms of angiogenesis
43. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors
44. Endothelial growth factor receptors in human fetal heart